1 completed, 1 terminated. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 1, Terminated 1 |
Follow ATM-AVI: new trials by email Literature Review of ATM-AVI trials Research Report on ATM-AVI
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy, Safety, and Tolerability of ATM-AVI in the Treatment of Serious Infection Due to MBL-producing Gram-negative Bacteria ATM-AVI, BAT - Serious Bacterial Infection | Phase 3 | Terminated | Pfizer | 15 | 2020-12-25 | 2024-02-02 |
| A Study to Determine the Efficacy, Safety and Tolerability of Aztreonam-Avibactam (ATM-AVI) ± Metronidazole (MTZ) Versus Meropenem (MER) ± Colistin (COL) for the Treatment of Serious Infections Due to Gram Negative Bacteria. ATM-AVI, MTZ, MER - Complicated Intra-abdominal Infection, Hosptial Acquired Pneumonia | Phase 3 | Completed | Pfizer | 422 | 2018-04-05 | 2024-12-10 |
Pneumonia, Ventilator-Associated (1)
Pfizer (2)
Argentina (2) · China (2) · Greece (2) · India (2) · Malaysia (2) · Mexico (2) · Philippines (2) · Romania (2) · Russia (2) · Taiwan (2) · Thailand (2) · United States (2) · Bulgaria (1) · Croatia (1) · Czechia (1)
PMID 38252170, PMID 40530972, PMID 41269522, PMID 39389071
2017 (2)